N
Google TrendANNA BONDAR (200+) — October 11, 2026: Lilli Tagger vs Nikola Bartunkova: Set 1 Winner Prediction Market
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:anna bondar200+natanael cano100+green card500+power outage near me10000+india2000+sony playstation1000+loki100+hubert hurkacz200+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "FDA Approves First Treatm" (30 stories)

Top Headline Story

FDA Approves First Symptomatic Dermographism Treatment
Lead StoryAJMCgeneral
3d ago

FDA Approves First Symptomatic Dermographism Treatment

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxNY0RqRUEwQkdybXVWdGR4c2tjX2dmR2V5LWkzVGhqNnNoNlNEalk0TjJ5ajJtSFBYMDV5WVpjWnU4WWR3WUZiUlAxSkNIWnhtZVlLNTNEQ3R1VTB0WFY0RTdSeWZKWXZoSjA2YUM2NnlfbFJEN0p0MXVVaWZ2Y0ZCNEw1RGc1dVk?oc=5" target="_blank">FDA Approves First Symptomatic Dermographism Treatment</a>  <font color="#6f6f6f">AJMC</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+16m ago

anna bondar

October 11, 2026: Lilli Tagger vs Nikola Bartunkova: Set 1 Winner Prediction Market

Filter stories
100+16m ago

natanael cano

Padres de Natanael Cano rompen el silencio tras retiro del cantante: "Es por el bien de nuestro hijo"

Filter stories
500+26m ago

green card

Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows

Filter stories
10000+26m ago

power outage near me

LIVE | Atlanta weather: Power outages, tree damage remain as storm threat moves east

Filter stories

Search Results for "FDA Approves First Treatm"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
FDA Approves Tukysa Plus Trastuzumab and Pertuzumab as First-Line Maintenance Treatment for HER2-Positive Metastatic Breast Cancer
Pharmaceutical Executivetech

FDA Approves Tukysa Plus Trastuzumab and Pertuzumab as First-Line Maintenance Treatment for HER2-Positive Metastatic Breast Cancer

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQQXhheEFyaG9Zb2xQb2V1ZTZpZ1cyLUY0T0UxN014S2FMQUt3Y1doWGJaR0pTaWRmZGhpX0xzY3ZySjRhT04zeUtKV0JHcktSdFUzc2xHamRJbmRqMVRvTl90clVXRjlieF9aX05aT3R1NTBpWU55ZG5HTlJiRUZSTjlYcGgweG1ZRy01QUdaYVp2VkJ0TVhCOXNYa0k2WFpkX201elpTLWc1MENOcTltMHh3?oc=5" target="_blank">FDA Approves Tukysa Plus Trastuzumab and Pertuzumab as First-Line Maintenance Treatment for HER2-Positive Metastatic Breast Cancer</a>  <font color="#6f6f6f">Pharmaceutical Executive</font>

Read Full StoryMore like this
FDA Approves First-In-Class Med for Parkinson's Disease
Medscapegeneral

FDA Approves First-In-Class Med for Parkinson's Disease

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQVkJmZVFjYkR2UzVNWF8yRFh2d2xtRDdtNFRrbVlTMGx6OU0wSEpkSHM2R19neWYzWmV5ZTBmUkNFbVRuYXJNR3dzTHZyU2t1X28zZ3hYUGRGV3pzWEFTTHQ2S0RXOHpzQTBTZW9Oa2d1eVdaS254cUlEN2s3X1FpNUpGOHdmQXhFWHN5X2hRcFRkYWlZLXZyYlJoZmd3QQ?oc=5" target="_blank">FDA Approves First-In-Class Med for Parkinson's Disease</a>  <font color="#6f6f6f">Medscape</font>

Read Full StoryMore like this
FDA Approves Tiratricol, First Treatment for MCT8 Deficiency
Pharmacy Timesgeneral

FDA Approves Tiratricol, First Treatment for MCT8 Deficiency

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQc2RvSHZMbUhMQzhoYjBvZTVDcnYwMExFSFFKbFV2N1RoalVQcGxDTjFfd19PSnRtelVKMEVJU3VwVkVHcXBZWk10dGVXcnRhOUNVSlctbUQ0VFk5Ui1wd0oxSklseVdmVjBqZVFMLXlqQ1c4Ym9RUnNIYzZONDNpQUJzdFdNcnd4SFEzS0hnRE9DZmFBVkpxcmVn?oc=5" target="_blank">FDA Approves Tiratricol, First Treatment for MCT8 Deficiency</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
FDA Approves First Drug To Treat Alexander Disease After 30 Years of Research
SciTechDailygeneral

FDA Approves First Drug To Treat Alexander Disease After 30 Years of Research

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQZHhLaldGUU5Ra3JaUTVjdTRuR2Zndk8zclVydHFjN09oYkt2X1ZYT1BPckNIem1UOFRTTkItWE05WXlWYUF5YUhlcjhmSjFOZ25YckVLQmdMRVZHbW1yQ0lRT3JvMkRHNnpQS0R5Um1MNFpteklhWndWQ19FSTRCc1B4dlV4TjBGODFLbjJIdWJLUXNEOUUtY3hUSVlieDVGVlk3U3BR?oc=5" target="_blank">FDA Approves First Drug To Treat Alexander Disease After 30 Years of Research</a>  <font color="#6f6f6f">SciTechDaily</font>

Read Full StoryMore like this
Novartis Rhapsido® (remibrutinib) receives FDA approval as
GlobeNewswiregeneral

Novartis Rhapsido® (remibrutinib) receives FDA approval as

<a href="https://news.google.com/rss/articles/CBMi1gJBVV95cUxNcHNfZ2o3ZXhkS2lJQmtsWEcxaEV4TDFVSDJpTXhaN21OUDFKZm11SndnQ3lqQ3luaUktQXRXNjJZR3IyYWFIcHFSLVpTWkhiVjBpNlNWS3Z6c2FmMHlNSXRGNlJIRl9sZExLaGNOc0UzY1R2VVdBTUhqcVFXanl4YlhONG55RWJXakRjUGZ4Y0dWazJqUk5UZHNJaEZacFhvZXBacnVBMUlnNWtwNVV6bTRINGZHd1RRdWFmakNtS3c5ZzJmbHU5M1MyZDRIeUQ0ckxZYWh1SkJzc2RDR29sTjRwazZUUEsydTFjTnBfZnhaT3FVVHJBdXAwYThFUjMtZkp3YWlKazN1VVpSNlM1Q0lSbUhjTV9Sd1J2cnVjRXJ4dnRyVHdnamw5RC1ja05JbS1kQzN3UzlMemhFNEhDNnVvazJjOWhlSVQycTV5amVNN0ItSXc?oc=5" target="_blank">Novartis Rhapsido® (remibrutinib) receives FDA approval as</a>  <font color="#6f6f6f">GlobeNewswire</font>

Read Full StoryMore like this
FDA approves first-ever drug to treat life-threatening disease: ‘A landmark moment’
MassLive.comgeneral

FDA approves first-ever drug to treat life-threatening disease: ‘A landmark moment’

<a href="https://news.google.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?oc=5" target="_blank">FDA approves first-ever drug to treat life-threatening disease: ‘A landmark moment’</a>  <font color="#6f6f6f">MassLive.com</font>

Read Full StoryMore like this
FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease
STATgeneral

FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxQdVl6aVRmQVhsZWRGNDNKUmVuOXo0Q1dkN3dDYkF5bWZNd29RblRBUnl3OXEtSlowdGx0d2dRZERsYm9LZUVZRFA5eC1pUnRUaWZoVHpQMndDdmt1eC1RQlU5WTFtRlp3SnJPTlZUM3VXcFZ4enZEbzJ5dEhJd0drdVROUUpodHZoUDY5akZ6SQ?oc=5" target="_blank">FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease</a>  <font color="#6f6f6f">STAT</font>

Read Full StoryMore like this
FDA Approves First Treatment for Rare Thyroid Hormone Disorder
MedPage Todaygeneral

FDA Approves First Treatment for Rare Thyroid Hormone Disorder

<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE5nd1RvZVRPeGx4YnpLQk0xaXg2d2t5Y0VNeFNkbWJzV0RPcHBvRzlrVWZmM3BUdDJKU19DREhwUTBsbnQtT0ZEZU8xSmlyeFAxTmtBZmRaX1A0Z19wc0lFMkZlbElmVjRU?oc=5" target="_blank">FDA Approves First Treatment for Rare Thyroid Hormone Disorder</a>  <font color="#6f6f6f">MedPage Today</font>

Read Full StoryMore like this
FDA approves first treatment for thyroid eye disease
Medical Xpressgeneral

FDA approves first treatment for thyroid eye disease

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxOTDZjbUtFSXlsLTlCMFNCQTdLNmVWS2kzaGpZaDVsb0lUVDBZWEZtampkN0lEWjQ4UFl1STMyQmtrTWdTa1NXMHJRYWR4aHdHWGlOMF9QXzVDcHFOaW5fUkVsMm5jTjlSZzFoTm9GU1l2MkYxUjZYcWdqMWF2VVRkZ3lkRQ?oc=5" target="_blank">FDA approves first treatment for thyroid eye disease</a>  <font color="#6f6f6f">Medical Xpress</font>

Read Full StoryMore like this
FDA Approves First Treatment for MCT8 Deficiency
finchannelgeneral

FDA Approves First Treatment for MCT8 Deficiency

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNbUhiM3RHaGNjZHpOY3lxMDl1S1hzNzRjVTU0ZThQX3lkTGVfVWhRaklfV1AwOWMwOG85ZjdtMDlpT1BGd0h1M2JnSlNuVk1DRTFvQThRR1RvbDVzdHQwT1BnNTVOTmFZc3plc25lOUQ0eFBXd0VNakdWcHRfaHlhRmh6YjdxU2ptNFJubUdTVklMdFdqREJvVGNYSVkxUkhON21r?oc=5" target="_blank">FDA Approves First Treatment for MCT8 Deficiency</a>  <font color="#6f6f6f">finchannel</font>

Read Full StoryMore like this
FDA approves first gene therapy to treat glycogen storage disease type Ia
Healiogeneral

FDA approves first gene therapy to treat glycogen storage disease type Ia

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxOVmE4U2tNdHBMWEZ1N3U0UXBpdEk4Y3NmRTBkZXRxNlRQVm9DaFJLRDdqejhNU1RUUEp3a0dNTEQ0ZmJzRzR0S1htbTJJOWJsRndsa3N0RGtINjhvUk93MURRRnB1M3hSOUtfQ2ZQVC13OEloMzJ4eVY0aUxaYzFpYm82amJBSWJQdjNhZGxqamFDdUhRbUVpd1ZBeXdmd0o2dVdMeXVPQ05Wc0V4ZzdUdHJqMWk4VVhteTJ2RVlOSy04UQ?oc=5" target="_blank">FDA approves first gene therapy to treat glycogen storage disease type Ia</a>  <font color="#6f6f6f">Healio</font>

Read Full StoryMore like this
FDA Approves Zilganersen, First Treatment for Alexander Disease
NeurologyLivegeneral

FDA Approves Zilganersen, First Treatment for Alexander Disease

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxQMjFOV1dfQTJ2TDlhTU50eXNXR3ZNeW5Bb0Q5WDg4azV4aFZuUlpXQUlRU014WDh6U19vRkd2NVpmRnA0aURkSEk5S0Z1U3FxTFFHTVR0U09fLXFhZWxrSXJUdmxnYW1jOFZpcV82bG54V21wYzJHUE5EYUFzNERNMU9qb2JKbTFfb21LMEpabTBIcmdBN0FvMQ?oc=5" target="_blank">FDA Approves Zilganersen, First Treatment for Alexander Disease</a>  <font color="#6f6f6f">NeurologyLive</font>

Read Full StoryMore like this
FDA Approves First Oral Treatment of Dermatomyositis in Adult Patients
HCPLivegeneral

FDA Approves First Oral Treatment of Dermatomyositis in Adult Patients

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxQWUpvX2dqNWY3YUs0WDFiOF9WcEtvUFFoTk9FU0VxckZIZ3hEdEtTbWVFQXpWMFVQYkxPZXpkMmRSQ3dnMk82Y3owMjVhTW45OFZsdmQybGVHaDRYS1ZYcU5OYllvck45UXlidlBVeW1GTm9aUzhRbzRqdnN6MXA2aTZWeWdiUGZ0TWhhekEwcHBNaDhNaTNmRw?oc=5" target="_blank">FDA Approves First Oral Treatment of Dermatomyositis in Adult Patients</a>  <font color="#6f6f6f">HCPLive</font>

Read Full StoryMore like this
FDA Approves First Targeted Therapy for Dermatomyositis
Muscular Dystrophy Associationgeneral

FDA Approves First Targeted Therapy for Dermatomyositis

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPbW9LV2NwWmZiWDVQeXV6Y0g0Yi1wOW1KUk1kRTduOC1PTjlLRjN5MnNpOE1TYk5OZGJzRUN5Ylh2R1J4V3M0bDNLTFliYk1yMnhhYi1WUzFNYjA3ZFM5UHlzS0VQbEd5eVZITndDamFlZnBfR3F6Z0VjRnZVbFlXV0RMTXlJZWV0NGFBTTR4OUJUVnVv?oc=5" target="_blank">FDA Approves First Targeted Therapy for Dermatomyositis</a>  <font color="#6f6f6f">Muscular Dystrophy Association</font>

Read Full StoryMore like this
FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A
CGTLive®general

FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPam96bXpPUE9VY3RzcHhQNEEtMU5HZnNKNlEyamt3SzRUMF93VXBJOUlLMUxjb1ZvVFZpZTF6Qjg2RWQyVlp5eGk0MFNDcjRoS1ZpYzNXcjhJc1BlRzBvZHhCbmZqUGo1NHRPempDR0dzb1lCeWhsbGd2SmVZcXBLaDJKRGJhcl9fenlZNXBmOG1VdDFRQWc?oc=5" target="_blank">FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A</a>  <font color="#6f6f6f">CGTLive®</font>

Read Full StoryMore like this
FDA approves first RAS-targeted therapy for metastatic pancreatic cancer
News-Medicalgeneral

FDA approves first RAS-targeted therapy for metastatic pancreatic cancer

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxPeGdzRERnRi1SRGt4T2JTR056MXNSRFNPdy02WUhBS0duYmh5TWlMcU1IVzJxTjF3R3Z6LWZnT2ROWC1YSkdETmdmMmxxdUstbTQtY0M2aHJJZWhUY0xPRzRiZ1d1SmRUSVl4amdTdGJmRGRZVkFETlZBRUZpc1YxSXNROTllT0xQTUZKMzVKWXRod3NrdUNncjkxOVptNU1ra2dKR0ZFaklXcmtWTXF0eVMzRVdaV2cwZDdiQg?oc=5" target="_blank">FDA approves first RAS-targeted therapy for metastatic pancreatic cancer</a>  <font color="#6f6f6f">News-Medical</font>

Read Full StoryMore like this
FDA Approves First Treatment for Sanfilippo Syndrome Type A
AJMCgeneral

FDA Approves First Treatment for Sanfilippo Syndrome Type A

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNWEVuNGtTWXo4Y1UwQzRmaVN3dHFteWEzNEY2RHF3b3V0RXZPNHpiVk10SUw1QmxDUjM0MlVRMmloS2hYMmRDbFdsLWt2RmJtNFpna2N3dm1EbnRzZGV1VGRCMGpFV1NWRkNsQ1R1NVV5RGQ3VTRQRW5BOHl2UTN1aXcyREwwVkxQcExhNzF3?oc=5" target="_blank">FDA Approves First Treatment for Sanfilippo Syndrome Type A</a>  <font color="#6f6f6f">AJMC</font>

Read Full StoryMore like this
FDA Approves Rebisufligene Etisparvovec as First Gene Therapy for Children With Sanfilippo Syndrome Type A
Pharmacy Timesgeneral

FDA Approves Rebisufligene Etisparvovec as First Gene Therapy for Children With Sanfilippo Syndrome Type A

<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxQLTV2MDB3bDYyU0NLeDZtX0p0TDJ4SVB6Q19obk44OXRLT0pHX0JHcXdXalBseFJyZFVtWmYtbnBKeTdwaVNrSy1Jd3VsQTdDTEFrbTBnNkxiTHVUY04tZ2RSQTRLbktiNFg0czgyZU1SU3VhNVI0dEtQTnJRUk5yRTg0a3k1R1M3d29xRzh3cGFkOFhRUTlOdEVHSjI3bEFDMW1DVDJMbW9YdHZMZHdjdVY1OFdab1JYOXh3SFJnd1dXb3ZESmhlb3FQYWd4MDl0Zm41bHY4ZDQ?oc=5" target="_blank">FDA Approves Rebisufligene Etisparvovec as First Gene Therapy for Children With Sanfilippo Syndrome Type A</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
FDA Approves First NDSRI for ADHD in Adults and Children
Medscapegeneral

FDA Approves First NDSRI for ADHD in Adults and Children

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQdmFVTXJvZFRVZlNPM3dldWdMV0gxUzBqbXNYa1F6d1pCR1ViclJEWEdXWHdfWUJicHBYQVZ0RUg2Z2piZU8xRXRaUWJLY3JDNDhoZXBiaTNrWEptZGwxellrelZ5b3VWR0FnRVhwUVJBSlNhR01xNUtoVGNmdk9sYno1RjBtTEVxR0VEWE5va1FRN2hxaDIwWXdWTUZnZVZk?oc=5" target="_blank">FDA Approves First NDSRI for ADHD in Adults and Children</a>  <font color="#6f6f6f">Medscape</font>

Read Full StoryMore like this
FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients
PR Newswiretech

FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients

<a href="https://news.google.com/rss/articles/CBMisgJBVV95cUxOWWhuSXBROXpxLVhpZlFzWDh2VDhURjNRc1BuQXV6V3g4MUJXQUljRjlTTGxyXy00OE9oemhkY2dPa29HT0hDUDlSeDVFVVhvblRzVWFUNFlmY2ZEeWdFbEMtYXV5QW1Fb2ZfZ2tIZ1V1QjhzWUJlX2NTc2RLc2RjLWhrY01PZzJzSldwbHgzS2ZLS2NOMTg4bVd3YWFRVnc3OGVqTDNHUk41cVZKZWk4RndaN2JNUXFCY3RfU050MlRuWVl3Rkl4OG1kenlBTk1jOFpDN3NIZmdBSmNPWlJGVGlSSU0tUS15YlpyODNrcExieHdBTVk4VDhPRU9TYlUtbEhHekhzdGxqczA0S0R5eHdHWS1WYmh5SXplSUFRREk5WURNdGJUODk2LU5wZDczVnc?oc=5" target="_blank">FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
FDA Approves First Treatment for Warm Autoimmune Hemolytic Anemia
HCPLiveworld

FDA Approves First Treatment for Warm Autoimmune Hemolytic Anemia

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNQWdkTUo5ZE1wTlRaUm96bnVHT2tiLXYzUF9kS2JDeEwwWll0TUJoQUlBUXBRcXVHczF5MnkzY2tkQUlfSDZ0dVhzMlVwMENkOUdoOTZ6TWJsNmR5LV9UUFBBNW94Njd5MWN3Y0hRRkZrdkI1LXZrell1QjloVV9haUpNUmxKWEtHRTAzRmZxYV9FQ245eWgxVnB3?oc=5" target="_blank">FDA Approves First Treatment for Warm Autoimmune Hemolytic Anemia</a>  <font color="#6f6f6f">HCPLive</font>

Read Full StoryMore like this
FDA approves first treatment for MCT8 deficiency
Gulf Coast Mediageneral

FDA approves first treatment for MCT8 deficiency

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOUTlOdTBKQlZPWDE3ZGNBTVduanVJb2NLMTl4Y3ZJckpOOGs1Q2tTdGtWcDZ2TkhKNmZJQmE2TXg2ZVlJMFl1UE1CdTlreUNjTmlpNWJiUjBNbXRkYWlVdzlGbDl1M3QtaklVcG5jd3RCb0dlRHNlTXBQTHlWRUhqZ2JQQkFNVHVCenVza1ZkMkJ5Sl9R?oc=5" target="_blank">FDA approves first treatment for MCT8 deficiency</a>  <font color="#6f6f6f">Gulf Coast Media</font>

Read Full StoryMore like this
FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A
The Medicine Makergeneral

FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNUmZaRzZ6WHhGV194T0JqaThZWmpZMjBlY1ZNX0xTWnQ4ZGFxMjhOUklJQkhqZ1NSYmtzUVFUOVJwd3c4RU16cmUyQ2tjMFpxX3hlUzZIcFB0YTRSQ3RJV3N2cUVhSDFSaF9udkVZNU5NN21EMGpQcC03c3JVRkxSXy1GLV82THdxWnlDeUY3SkU4SndDLWZGRGphUmwwanZlSzF5NjBYcU5JellWODI0NjZZRFZ0bmhKamREcDhLNnU?oc=5" target="_blank">FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A</a>  <font color="#6f6f6f">The Medicine Maker</font>

Read Full StoryMore like this
Ultragenyx Announces U.S. FDA Approval of GENGLYCOS™ Gene Therapy, the First-Ever FDA-Approved Treatment Designed to Treat the Underlying Cause of Glycogen Storage Disease Type Ia (GSDIa)
Ultragenyxworld

Ultragenyx Announces U.S. FDA Approval of GENGLYCOS™ Gene Therapy, the First-Ever FDA-Approved Treatment Designed to Treat the Underlying Cause of Glycogen Storage Disease Type Ia (GSDIa)

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQY0cwS1JEdG8xZGZEelNuV2hTcmNYZGxkbS1mRnd0eDhPVDBIQzVRMVFXbHVSRWp3d2ZZQ0ctR0VpMTkzakJ3VU1ma204TFppZmdZSmhJU3dkSE9FS0t4VmhrNDYzMGRIQ25QaE1zdVoyTy1SRWl5SWt5WkNJSzBPV1o5VlFKZ1ZZVHhWNkQ3dUVBM1BKRkNkeWNGbDFuWUROOFAzTW9qWFViUi0wdGN5T3I2OWtCUE9SQ2NYQS1QNA?oc=5" target="_blank">Ultragenyx Announces U.S. FDA Approval of GENGLYCOS™ Gene Therapy, the First-Ever FDA-Approved Treatment Designed to Treat the Underlying Cause of Glycogen Storage Disease Type Ia (GSDIa)</a>  <font color="#6f6f6f">Ultragenyx</font>

Read Full StoryMore like this
FDA Approves Nipocalimab-aahu as First Treatment for wAIHA
The American Journal of Managed Caretech

FDA Approves Nipocalimab-aahu as First Treatment for wAIHA

<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxQOE94TE4wZmxRTzI5d1J4aUMtLUlLNjlrVTJldjl3YzZIWlVaMzJBY3gxaEpBUzV0SVV1SlFBRUJqVGIxMGNmTnAxUWhLNno0MTFVVFo1cHJpbi1VY05JNVFmenRITDFTbFZYWWFWUjVPV0NzbGlJd3RVa1BqemJRQ1JhQW9XRU95ZzM1dw?oc=5" target="_blank">FDA Approves Nipocalimab-aahu as First Treatment for wAIHA</a>  <font color="#6f6f6f">The American Journal of Managed Care</font>

Read Full StoryMore like this
FDA approves first treatment for Alexander disease, Zanvastro
FindArticlesgeneral

FDA approves first treatment for Alexander disease, Zanvastro

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE84QWRHN0JmX0MweDI4b0lqTzFCc3FDSmszS3I3UEFpckZuQzNpODVBcHJqeUZZMTBPMFNOaG5vRkpwNVFtZkdKZE11bE5pclJlTTg1U3pIdE5NY29TV0tScURZaXNQSEs0V2RPVDhwWDJ4VGU3aEkzbHJ30gGCAUFVX3lxTE4wZGV3ZV9KeGZLRFA4ODRjX2ViWXgwNGVZN1BsVk1BNXlzQnE5VThJeWlqeEpoZFZOb0w4RG83SDEzcHp5eXZ0RG84d2loemI2WEt2NG1RcGVPMS1DZ2x0Rk9ITjYxdlhwZzNrZWhpeXduOHZSWERoeFlfM1h4Yk1iT0E?oc=5" target="_blank">FDA approves first treatment for Alexander disease, Zanvastro</a>  <font color="#6f6f6f">FindArticles</font>

Read Full StoryMore like this
FDA approves first-of-its-kind treatment for most common form of pancreatic cancer
Scripps Newsgeneral

FDA approves first-of-its-kind treatment for most common form of pancreatic cancer

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQaGpfWGstVnhxbXNRYjByeEc4WUZOSDJ5Yk54cEtmR1J3SGlTcnBFSzVJUFAxVlZYcUtwNmJQenB3UDNfcXhGWTNkT0tCVDROUUdhb0xvWDljLWZxbzRucU5aZnl6TC1mYUg3N0hLdDBpVUlYZi1LTU1HY3R3QW02dUp1Zk5GbnpkakR3TFF2R3FRTjRIRlducnpZM1BfRzBPaEJRZGo0cThkRGxjSE42LXFCSHMtcVVX?oc=5" target="_blank">FDA approves first-of-its-kind treatment for most common form of pancreatic cancer</a>  <font color="#6f6f6f">Scripps News</font>

Read Full StoryMore like this
FDA Approves First Nonantipsychotic Treatment for Agitation Associated With Alzheimer Disease
Pharmacy Timesgeneral

FDA Approves First Nonantipsychotic Treatment for Agitation Associated With Alzheimer Disease

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxPeXFvYTI5NGh3N0VoMG5GWkM0eU16YlNYREtoRmJXZmNESFlTb3RjemNESXlZX3dZRm5LRmFfVEFjdVMzemhLUHMwNGtNSlM3MDRCVkRjZ2ZpVm94d2hRYVk1YTU5dWp0WjltQzRSWi15alMtS0dvSHNRRE5WUTlFUThMZllaMl92TU5JcXlVNzZJSzNOdUEwMllOcFRyWEZMek80QU5TbG5aOUFweEp6cTA5ajE1S3hGS3IwSG1oSlpndlJKbGJCeQ?oc=5" target="_blank">FDA Approves First Nonantipsychotic Treatment for Agitation Associated With Alzheimer Disease</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
FDA Approves Isembyld (apitegromab-mstn), the First and Only Muscle-Targeted Therapy for Spinal Muscular Atrophy, Marking a New Milestone in SMA Treatment
Muscular Dystrophy Associationgeneral

FDA Approves Isembyld (apitegromab-mstn), the First and Only Muscle-Targeted Therapy for Spinal Muscular Atrophy, Marking a New Milestone in SMA Treatment

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxPa0ZNS01rRUd5UzBEa05lX180dE1rUkdGTlVxT2djanNubzM2dkdZOXBLN0l2MWlaT3Q2M0RIN1hUelhjSEkxVVEwNEF3RDgwcERQZ0ppV0Z4b0g1VlR2Rkh3TEozZ01sX1hENk9PVUZ6UGRBQm9sUm1DX1hxX1J1V1ViRWRKaWlfakZZMEdqT19vVjJSVG1XUXV0c1AxTVdfbXBXR2t0dzhySFBqdTF5MTIwU3hrd2ZXMFFEZXZrYVkwMjVrMlE?oc=5" target="_blank">FDA Approves Isembyld (apitegromab-mstn), the First and Only Muscle-Targeted Therapy for Spinal Muscular Atrophy, Marking a New Milestone in SMA Treatment</a>  <font color="#6f6f6f">Muscular Dystrophy Association</font>

Read Full StoryMore like this
"FDA Approves First Treatm" — Live Google News Trends & Headlines